In addition, subgroup analysis of distinct glycolysis markers revealed a relationship between PKM2, STMN1, MCT4, GLUT1, HK-2, CA9, and GLUT2 and the clinical outcome of HCC patients. This evidence concerns the gene HK2 and hepatocellular carcinoma.